Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Wudhikarn, Kitsada  [Clear All Filters]
2019
Limvorapitak W, Owattanapanich W, Utchariyaprasit E, Niparuck P, Puavilai T, Tantiworawit A, Rattanathammethee T, Saengboon S, Sriswasdi C, Julamanee J, et al. Better survivals in adolescent and Young adults, compared to adults with acute lymphoblastic leukemia - A multicenter prospective registry in Thai population. Leuk Res. 2019;87:106235.
Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, Niparuck P, Chuncharunee S, Numbenjapon T, Prayongratana K, et al. Event Free Survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma. Hematol Oncol. 2019.
Srinagesh HK, Özbek U, Kapoor U, Ayuk F, Aziz M, Ben-David K, Choe HK, DeFilipp Z, Etra A, Grupp SA, et al. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease. Blood Adv. 2019;3(23):4034-4042.
Muhamad H, Suksawai N, Assanasen T, Polprasert C, Bunworasate U, Wudhikarn K. Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer/T Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance. Acta Haematol. 2019:1-11.
2020
Pennisi M, Jain T, Santomasso BD, Mead E, Wudhikarn K, Silverberg MLynne, Batlevi Y, Shouval R, Devlin SM, Batlevi C, et al. Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management. Blood Adv. 2020;4(4):676-686.
2021
Wudhikarn K, Padrnos L, Lasho T, LaPlant B, Kumar S, Dispenzieri A, Lacy M, Rajkumar SV, Gertz M, Mangaonkar AA, et al. Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapy. Am J Hematol. 2021.
2022
Wudhikarn K, Johnson BM, Inwards D, Porrata L, Micallef I, Ansell SM, Hogan W, Paludo J, Villasboas J, Johnston P. Outcomes of older adults with non-Hodgkin lymphoma undergoing autologous stem cell transplantation: a Mayo Clinic Cohort Analysis. Transplant Cell Ther. 2022.
Wudhikarn K, King AC, Geyer MBlaine, Roshal M, Bernal Y, Gyurkocza B, Perales M-A, Park JH. Outcomes of Relapsed B-Cell Acute Lymphoblastic Leukemia After Sequential Treatment with Blinatumomab and Inotuzumab. Blood Adv. 2022.
2023
Tawinwung S, Tudsamran S, Thaiwong R, Asawapanumas T, Wudhikarn K, Chanswangphuwana C, Hirankarn N, Bunworasate U, Suppipat K. Improving cytokine-induced killer cell expansion using a gas-permeable culture method for clinical-scale production. Asian Pac J Allergy Immunol. 2023.
2024
Spyrou N, Akahoshi Y, Kowalyk S, Morales G, Beheshti R, Aguayo-Hiraldo P, Malki MMAl, Ayuk F, Bader P, Baez J, et al. A day 14 endpoint for acute GVHD clinical trials. Transplant Cell Ther. 2024.